Henrotin Yves

HENROTIN Yves is Professor of Pathology, Physical & Manual Therapy and Rehabilitation and director of the Musculoskeletal Innovative Research Lab (mSKIL) at the University of Liège (Belgium) www.mskil.uliege.be. He is also head of the Physical Therapy and Rehabilitation department at the Princess Paola Hospital, Marche-en-Famenne, Belgium. He is a member of the Osteoarthritis Research Society International, the French Society of Rheumatology and the International Cartilage Repair Society. Between 2006 and 2013, he was a member of the board of directors the Osteoarthritis Research Society International (OARSI), the premier organization focused on the prevention, diagnosis and treatment of osteoarthritis. He was elected treasurer in 2010 and chairman of the group for guidelines in clinical trial in 2015. He was chairmen of the world BMJD debate and consensus congress in 2010 and 2012 and chairman of the 2010 OARSI world congress. He is also the vice-president of the Spine section and the Osteoarthritis section of the French Society of Rheumatology and serves the board of the French Society of Rheumatology between 2011 and 2017. He was the founder and the president of the Belgium Back Society since 2000 and the president of the Belgium Scientific Society of Physical Therapy since 2008. He was the Belgium delegate and board member of the COST B13 action “Low back pain: guidelines for its management” organized by European Commission Research Directorate General. He was coordinator of the WP 1 of FP-7 programme D-BOARD, an European consortium dedicated to OA biomarkers research. He is a principal investigator of the Belgian “Excellence of Science” (EOS) consortium named “preservation and repair of joint: meeting the osteoarthritis”. He is co-President of the board of the National Council of Physical Therapy and Rehabilitation for the Belgium Health Ministry. He is honorary editor-in-chief of International Journal of Orthopaedics and member of the editorial board of Osteoarthritis Cartilage, Annals of Physical and Rehabilitation medicine and Journal of Experimental Orthopaedics. In 2018, he was integrated as a member of “Communication & Publication” standing committee of International Cartilage Regeneration & Joint Society (ICRS). He has published over 260 scientific peer-reviewed papers and 10 chapters of book h index 53). He is the co-editor of the book “Osteoarthritis: clinical and experimental aspects” (Springer), co-editor of “Primer in OA” (edited by the OARSI) and editor of the book “Nonpharmacological modalities for the management of osteoarthritis” (Bentham). In 2005, he received a prestigious national prize (De Cooman Prize) for his contribution in the better understanding of osteoarthritis pathophysiology. He is also the founder and the chairman of the board of the spin-off company of the University of Liège: Artialis SA, a company specialized in the research and development of biological markers of musculoskeletal disorders www.artialis.com. Thanks to this professional structure, Prof Henrotin manage many drug development from the preclinical screening to phase III clinical stage. Finally, He is also the founder and the President of the Osteoarthritis foundation www.osteoarthritisfoundation.eu.